Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus "treat All" Adoption in Uganda

10Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All"in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/μL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.

Cite

CITATION STYLE

APA

Nasuuna, E., Tenforde, M. W., Muganzi, A., Jarvis, J. N., Manabe, Y. C., & Kigozi, J. (2020). Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus “treat All” Adoption in Uganda. Clinical Infectious Diseases, 71(9), 2497–2499. https://doi.org/10.1093/cid/ciaa261

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free